Furthermore, the EphB2 gene was identified as a novel transforming growth factor (TGF)-β target that is important for the TGF-β3-mediated migration and invasive of breast cancer cells, and its transcriptional activation by TGF-β3 was also suppressed by p53 (Lam et al., 2014). This evidence concerns the gene EPHB2 and breast carcinoma.